[CLDX] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
05-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- -6.09%
YoY- -14.91%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 1,425 4,068 1,534 1,303 486 416 2,414 -8.40%
PBT -17,239 -118,897 -34,261 -34,673 -30,174 -29,903 -17,332 -0.08%
Tax 5,234 -765 5,098 -2,062 -1,614 -1,586 -379 -
NP -17,239 -118,132 -34,261 -34,673 -30,174 -29,903 -17,332 -0.08%
Tax Rate - - - - - - - -
Total Cost 18,664 122,200 35,795 35,976 30,660 30,319 19,746 -0.93%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin -1,209.75 -2,903.93 -2,233.44 -2,661.01 -6,208.64 -7,188.22 -717.98 9.08%
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS -1.40 -12.61 -4.19 -5.27 -4.90 -5.02 -3.51 -14.19%
EPS Diluted -1.40 -12.61 -4.19 -5.27 -4.90 -5.02 -3.51 -14.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.